Bank of America Report is Bullish on Cannabis Testing

DigiPath Inc. (OTCQB: DIGP), a provider of reliable testing, education, training, and news coverage to the cannabis industry, was recently featured in a Bank of America investment report titled Medical Cannabis Has High POTential: A Joint Biotech & Tools Primer.

In the report, Bank of America analysts single out cannabis testing as an area likely to experience enormous growth within the industry. The report suggests that cannabis testing could reach $800 to $900 million in size by 2020 as the $2.9 billion medical cannabis industry appears poised to at least double. Cannabis testing services and lab equipment should experience heightened demand as the industry matures.

DigiPath Labs, a leading cannabis testing facility in Nevada, foresaw the growth in demand for cannabis testing and the tightening of regulations on testing methods and equipment and capitalized on the growing market.

Read the entire press release here:

DigiPath, Inc. (DIGP) was recently named in...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.